OIA Response: Pertuzumab renewals data

Request dated 29 April 2019 for number of Special Authority renewals for pertuzumab for 2017, 2018, and 2019.

[Name and contact details redacted]

22 May 2019

Dear [Name redacted]

REQUEST FOR INFORMATION

Thank you for your request dated 29 April 2019 under the Official Information Act 1982 (OIA). 

You asked for the number of special authority renewals for pertuzumab (special authority form SA1606) by month for 2017, 2018 and 2019.

Please find the information requested in the table below.

Pertuzumab – Special Authority (SA1606) renewals by month of submission

Financial Year

Month Submitted

Renewals

2017

2017-04-01

1

2018

2017-09-01

1

 

2017-11-01

1

 

2017-12-01

2

 

2018-01-01

7

 

2018-02-01

4

 

2018-03-01

6

 

2018-04-01

13

 

2018-05-01

9

 

2018-06-01

8

2019

2018-07-01

3

 

2018-08-01

4

 

2018-09-01

2

 

2018-10-01

7

 

2018-11-01

3

 

2018-12-01

2

 

2019-01-01

2

Please note that PHARMAC approaches its assessment of requests for information under the OIA on the basis that, once released, the information becomes publicly available - in other words once we release the information to you it becomes available to any other party in that exact form (whether by you distributing it to others or by virtue of us receiving the same request from a different third party). 

We trust that this information answers your queries.  We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website.  Please get in touch with us if you have any questions about this.

Yours sincerely

[Alison Hill's signature]

Alison Hill
Director, Engagement and Implementation